Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Drug Regulator Drafts Law For Power To Punish Unethical Trial Acts

This article was originally published in PharmAsia News

Executive Summary

The Drug Controller General of India is said to be drafting a proposal to give the health ministry power to punish companies that violate ethical standards in clinical trials. The proposed change would become a separate provision of the Drugs and Cosmetics Act in an effort to improve the country's image in the wake of the death of an infant in a trial that had a violation of ethics guidelines. The government now lacks the power to punish offenders because the ethical guidelines they work under are voluntary. Some experts say many pathology laboratories in India do not follow good laboratory practices and fake data. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069913

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel